500 Participants Needed

eIMPAQc System for Cancer Care

(eIMPAQc Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: St. Mary's Research Center, Canada
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Purpose: The Electronic Implementation of Patient and Caregiver Reported Outcomes across cancer centres in Quebec project, or e-IMPAQc, was launched in 2017. e-IMPAQc's goal is to actively engage patients, their caregivers, healthcare professionals (HCPs), managers, policy makers, researchers and IT personnel to co-develop, implement, and evaluate an evidence-informed electronic patient-reported outcomes (e-PRO) screening and management program across Quebec.Methods: e-IMPAQc built on the Improving Patient Experience and Health Outcomes Collaborative (iPEHOC) project, the first initiative in the province to implement e-PRO screening and was rolled out in three phases. e-IMPAQc has five main components: 1) primary and secondary standardized e-PRO questionnaires and algorithm; 2) summary report for clinicians with alert system; 3) summary report for patients, with tailored notifications regarding symptom severity; 4) self-management fact sheets library; and 5) clinical dashboard. Phase 1 included initiating change management and the co-development of the e-PRO algorithm with patients, their caregivers, HCPs, managers, policy makers, researchers and IT personnel (herein collectively referred as stakeholders) across seven cancer centres. The iPEHOC algorithm was used as a starting point given its successful implementation in one of the participating cancer centres for several years. Phase 1 also included feasibility work to establish a caregiver-reported outcomes (CROs) algorithm as well as the identification and configuration of appropriate electronic platforms on which to house e-IMPAQc. In Phase 2 the focus was on preparing for imminent implementation through workflow mapping and putting in place implementation support (e.g., site coordinators). A pilot of e-IMPAQc (excluding CROs) was also undertaken at one of the participating centres. In Phase 3, e-IMPAQc is being sequentially rolled out to as many cancer centres as possible and then evaluated. Qualitative and quantitative methods are used to document the process of implementation, patient and caregiver, and knowledge transfer (KT) outcomes.

Eligibility Criteria

This trial is for cancer patients receiving care at specific centers in Quebec. Participants must be able to speak English or French and use email and the internet.

Inclusion Criteria

Receiving cancer care at designated center

Exclusion Criteria

Unable to use email and internet

Timeline

Pre-implementation

Outcomes collected in patient populations prior to roll-out of the eIMPAQc

Not specified

Implementation

e-IMPAQc is sequentially rolled out to cancer centres and evaluated

4-6 months

Follow-up

Participants are monitored for outcomes such as patient activation, acceptability, and satisfaction

4-6 months

Post-implementation

Outcomes collected in patient populations after roll-out of eIMPAQc

18 months

Treatment Details

Interventions

  • eIMPAQc
Trial Overview The e-IMPAQc project tests an electronic system that lets patients report their health outcomes. It includes questionnaires, alerts for clinicians, reports for patients, self-management resources, and a clinical dashboard.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Post-implementationExperimental Treatment1 Intervention
Outcomes collected in patient populations after roll-out of eIMPAQc
Group II: Pre-implementationActive Control1 Intervention
Outcomes collected in patient populations prior to roll-out of the eIMPAQc

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Mary's Research Center, Canada

Lead Sponsor

Trials
11
Recruited
1,800+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security